Company
Propanc Biopharma, Inc. (PPCB)
Standardized SEC financial data for Propanc Biopharma, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001517681 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-423.7%
ROIC
-313.4%
Free cash flow
-$408K
Debt / equity
0.04×
Current ratio
1.50×
EPS (diluted)
$-14.85
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $180K | $231K | $256K | $248K | $248K | $224K |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $67K | $2K | $4K | — | — | — |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.8M | -$1.1M | -$1.4M | -$1.1M | -$935K | -$405K |
| Financing cash flow |
Get PPCB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PPCB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PPCB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"